Item 5.03.            Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective July 13, 2022, the Board of Directors (the "Board") of IDEXX Laboratories, Inc. (the "Company") amended and restated the Company's bylaws (as so amended and restated, the "Amended Bylaws") to modify, in part, the information a stockholder is required to include in its notice to the Company to nominate a candidate for election as a director to be consistent with the information requirements of the SEC's newly adopted Rule 14a-19 (b)(iii). Specifically, Section 1.10 was revised to require that the stockholder include in such advance notice a representation as to whether the stockholder intends (or is part of group that intends) to deliver a proxy statement and/or form of proxy to holders of shares of the Company's capital stock representing at least sixty-seven percent (67%) of the voting power of the shares entitled to vote on the election of directors (rather than holders of at least the percentage of the Company's outstanding capital stock reasonably believed to be sufficient to elect the proposed director nominee).

In addition, the Amended Bylaws also contain other minor, non-substantive changes.

The foregoing summary description of the amendments to the Bylaws is not intended to be complete and is qualified in its entirety by reference to the complete text of the Amended Bylaws, a copy of which is included as Exhibit 3.2 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description



                 Amended and Restated Bylaws of IDEXX Laboratories, Inc., amended through July
     3.2       13, 2022.

     104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses